Partners Steven D. Singer and Alfred C. Server, M.D., Ph.D., are each scheduled to moderate a panel at the BIO 2005 Annual International Convention to be held in Philadelphia, PA from June 19-22. Partner John Ratliff will also participate as a speaker. The firm will serve as a BIO 2005 Major Sponsor.
Steven Singer will moderate the panel entitled, “From Private to Public: Lessons Learned from the Class of 2004.” This panel will address lessons learned by several biotech companies that went public in the last year. Representatives from public biotech companies, the investment banking and legal communities will share their perspectives on the market, the risks and rewards of going public, and what they learned in the process.
“Technology Licensing and the New EU Competition Rules” is the discussion that will be led by Dr. Server. John Ratliff will join Dr. Server as a speaker on this panel that will discuss the recently adopted rules for technology licensing by the European Commission, which are of great importance to both established and emerging companies doing business in the newly enlarged EU. The panel will outline the new rules, focusing on working examples and highlighting implications for biotech and other life science companies and their advisers. This panel is part of the two-day meeting track, “Technology Transactions/Licensing,” of which WilmerHale is the sponsor.
Click here for time and speaker details regarding the above-mentioned panels.
Steven D. Singer, Esq. is vice chair of the Corporate Department of WilmerHale and co-chair of the Life Sciences Group. Mr. Singer has served as counsel for public and private companies in the life sciences sector, including biotechnology, medical device and pharmaceutical companies. His practice focuses on joint ventures and strategic alliances, corporate and securities laws, public offerings and venture capital transactions.
Alfred C. Server, M.D., Ph.D. is a partner in WilmerHale’s Corporate Department, and is co-chair of the firm’s Technology Transactions and Licensing Group. He focuses his practice on corporate biotechnology and forming corporate strategic alliances in the biotech field. Dr. Server has represented the firm’s clients in some of the most significant and highly regarded strategic alliance transactions in the life sciences industry. His biomedical training includes an M.D. degree and a Ph.D. degree (neurological sciences) from Stanford University, a medical internship at Peter Bent Brigham Hospital (a Harvard teaching hospital and predecessor of Brigham and Women’s Hospital), a neurology residency at Johns Hopkins Hospital, and post-doctoral fellowships in neurovirology and molecular biology at Johns Hopkins University and Harvard University.
John Ratliff, Esq. isco-chair of the WilmerHale’s European Antitrust and Competition Department. He has practiced EC competition law for more than 20 years and has been in Brussels since 1986 engaged in advocacy, advice and representation on a wide range of competition issues in all types of proceedings. Mr. Ratliff’s practice concentrates on European merger control, cartel defense cases, and competition remedies through complaints and other representations. He also regularly advises on the EC competition aspects of deal structuring in the life sciences sector.